Cargando…
Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up.
We examined bone marrow aspirates from 100 metastasis-free primary breast cancer patients. In 38/100 patients (38%), tumour cells were detected in the marrow using an immunocytochemical technique with a cocktail of two monoclonal antibodies: anti-EMA and anti-cytokeratin. Median follow-up was 34 mon...
Autores principales: | Harbeck, N., Untch, M., Pache, L., Eiermann, W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968873/ https://www.ncbi.nlm.nih.gov/pubmed/7510120 |
Ejemplares similares
-
Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up
por: Harbeck, N, et al.
Publicado: (1999) -
ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients
por: Fehm, Tanja, et al.
Publicado: (2008) -
Recent advances in technologies for the detection of occult metastatic cells in bone marrow of breast cancer patients
por: Braun, Stephan, et al.
Publicado: (2001) -
Intraoperative electron radiotherapy in early invasive ductal breast cancer: 6-year median follow-up results of a prospective monocentric registry
por: Philippson, Catherine, et al.
Publicado: (2022) -
Tenodesis with bone marrow venting under local anesthesia for recalcitrant lateral epicondylitis: results of 2 years of follow-up
por: Kenmoku, Tomonori, et al.
Publicado: (2022)